- Hamngatan 13
- 111 47 Stockholm
- Schweden
- stockholm@eib.org
Kontakt
Weitere Pressemitteilungen
Swedish company BioLamina to enable next-generation cell therapies for serious chronic diseases with €20 million EIB financing
The European Investment Bank (EIB) is lending €20 million to Swedish biotechnology company BioLamina to expand its development of laminin technologies enabling next-generation cell therapies and more advanced, animal-free methods for drug safety testing. Cell therapies can be used to target conditions such as type 1 diabetes, Parkinson’s disease, heart failure, acute liver failure and cancer. Many of these conditions remain difficult to treat or have no cure.
Sweden: EIB loan to help Stockholm cut wastewater pollution and protect the Baltic Sea
The European Investment Bank (EIB) is lending the City of Stockholm 5 billion Swedish kronor (around €470 million euro) to finance the city’s largest environmental investment in decades. The project involves closing the Bromma treatment plant and routing all the city’s wastewater to a significantly expanded and modernised treatment plant at Henriksdal.
Sweden: EIB launches first pre-IPO support to help European growth company access public markets
The European Investment Bank (EIB) has signed its first pre-IPO advisory agreement to help a European growth company prepare for access to public capital markets. The support is provided through the InvestEU Advisory Hub and aims to strengthen the ability of innovative European companies to grow and remain in Europe as they scale.